R&D Future glances: More change, more tech, more harmonisation According to Deloitte’s 2026 Life Sciences Outlook Survey, the life sciences sector might be becoming increasingly borderless, but only 41% of responding biopharma and medtech executives fe
Digital Garbage in, garbage out: The hidden data crisis in pharma This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
Digital Veeva Commercial Summit: On AI, content, and MLR Review with... At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial Content Strategy, Europe.
Digital Pharma’s new gatekeeper: AI’s rising role The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.
R&D Reimagining biopharma: How AI is reshaping discovery, develo... No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.
Digital Sponsored Precision medicine meets machine learning: AI and oncology b... A close examination of the current and future role of AI in biomarker discovery and the challenges that developers face in leveraging it.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.